{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:30:51Z","timestamp":1795141851878,"version":"4.10.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The triggering factors of sepsis-induced myocardial dysfunction (SIMD) are poorly understood and are not addressed by current treatments. S100A8\/A9 is a pro-inflammatory alarmin abundantly secreted by activated neutrophils during infection and inflammation. We investigated the efficacy of S100A8\/A9 blockade as a potential new treatment in SIMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The relationship between plasma S100A8\/A9 and cardiac dysfunction was assessed in a cohort of 62 patients with severe sepsis admitted to the intensive care unit of Link\u00f6ping University Hospital, Sweden. We used S100A8\/A9 blockade with the small-molecule inhibitor ABR-238901 and S100A9\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice for therapeutic and mechanistic studies on endotoxemia-induced cardiac dysfunction in mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In sepsis patients, elevated plasma S100A8\/A9 was associated with left-ventricular (LV) systolic dysfunction and increased SOFA score. In wild-type mice, 5\u00a0mg\/kg of bacterial lipopolysaccharide (LPS) induced rapid plasma S100A8\/A9 increase and acute LV dysfunction. Two ABR-238901 doses (30\u00a0mg\/kg) administered intraperitoneally with a 6\u00a0h interval, starting\u00a0directly after LPS or at a later time-point when LV dysfunction is fully established, efficiently prevented and reversed the phenotype, respectively. In contrast, dexamethasone did not improve cardiac function compared to PBS-treated endotoxemic controls. S100A8\/A9 inhibition potently reduced systemic levels of inflammatory mediators, prevented upregulation of inflammatory genes and restored mitochondrial function in the myocardium. The S100A9\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice were protected against LPS-induced LV dysfunction to an extent comparable with pharmacologic S100A8\/A9 blockade. The ABR-238901 treatment did not induce an additional improvement of LV function in the S100A9\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice, confirming target specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated S100A8\/A9 is associated with the development of LV dysfunction in severe sepsis patients and in a mouse model of endotoxemia. Pharmacological blockade of S100A8\/A9 with ABR-238901 has potent anti-inflammatory effects, mitigates myocardial dysfunction and might represent a novel therapeutic strategy for patients with severe sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04652-x","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:01:48Z","timestamp":1695956508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Therapeutic S100A8\/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction"],"prefix":"10.1186","volume":"27","author":[{"given":"Gabriel","family":"Jakobsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Papareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhongir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Ljungcrantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Engelbertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Bj\u00f6rkbacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Manea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Herwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Ruiz-Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rodr\u00edguez-Sinovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Schiopu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"4652_CR1","doi-asserted-by":"crossref","first-page":"i1585","DOI":"10.1136\/bmj.i1585","volume":"353","author":"JE Gotts","year":"2016","unstructured":"Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585.","journal-title":"BMJ"},{"key":"4652_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. New Engl J Med. 2013;369:840\u201351.","journal-title":"New Engl J Med"},{"key":"4652_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","volume":"46","author":"SJ Beesley","year":"2018","unstructured":"Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, et al. Septic cardiomyopathy. Crit Care Med. 2018;46:625\u201334.","journal-title":"Crit Care Med"},{"key":"4652_CR4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1378\/chest.80.5.579","volume":"80","author":"JE Calvin","year":"1981","unstructured":"Calvin JE, Driedger AA, Sibbald WJ. An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest. 1981;80:579\u201386.","journal-title":"Chest"},{"key":"4652_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11886-020-01277-2","volume":"22","author":"M L\u2019Heureux","year":"2020","unstructured":"L\u2019Heureux M, Sternberg M, Brath L, Turlington J, Kashiouris MG. Sepsis-induced cardiomyopathy: a comprehensive review. Curr Cardiol Rep. 2020;22:35.","journal-title":"Curr Cardiol Rep"},{"key":"4652_CR6","doi-asserted-by":"crossref","first-page":"1200441","DOI":"10.3389\/fcvm.2023.1200441","volume":"10","author":"T Shvilkina","year":"2023","unstructured":"Shvilkina T, Shapiro N. Sepsis-Induced myocardial dysfunction: heterogeneity of functional effects and clinical significance. Front Cardiovasc Med. 2023;10:1200441.","journal-title":"Front Cardiovasc Med"},{"key":"4652_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13054-018-2113-y","volume":"22","author":"F Sanfilippo","year":"2018","unstructured":"Sanfilippo F, Corredor C, Fletcher N, Tritapepe L, Lorini FL, Arcadipane A, et al. Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2018;22:183.","journal-title":"Crit Care"},{"key":"4652_CR8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardiores.2006.09.011","volume":"72","author":"JH Boyd","year":"2006","unstructured":"Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-\u03baB dependent inflammatory response. Cardiovasc Res. 2006;72:384\u201393.","journal-title":"Cardiovasc Res"},{"key":"4652_CR9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.yjmcc.2010.02.020","volume":"48","author":"R Fallach","year":"2010","unstructured":"Fallach R, Shainberg A, Avlas O, Fainblut M, Chepurko Y, Porat E, et al. Cardiomyocyte toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia. J Mol Cell Cardiol. 2010;48:1236\u201344.","journal-title":"J Mol Cell Cardiol"},{"key":"4652_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4266\/acc.2020.00248","volume":"35","author":"R Habimana","year":"2020","unstructured":"Habimana R, Choi I, Cho HJ, Kim D, Lee K, Jeong I. Sepsis-induced cardiac dysfunction: a review of pathophysiology. Acute Crit Care. 2020;35:57\u201366.","journal-title":"Acute Crit Care"},{"key":"4652_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.106.678359","volume":"116","author":"MW Merx","year":"2007","unstructured":"Merx MW, Weber C. Sepsis and the heart. Circulation. 2007;116:793\u2013802.","journal-title":"Circulation"},{"key":"4652_CR12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/AIA.0b013e3182603ec1","volume":"50","author":"DP Phillips","year":"2012","unstructured":"Phillips DP, Kaynar AM. Septic cardiomyopathy. Int Anesthesiol Clin. 2012;50:187\u2013201.","journal-title":"Int Anesthesiol Clin"},{"key":"4652_CR13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.07.015","volume":"167","author":"M Pruenster","year":"2016","unstructured":"Pruenster M, Vogl T, Roth J, Sperandio M. S100A8\/A9: from basic science to clinical application. Pharmacol Therapeut. 2016;167:120\u201331.","journal-title":"Pharmacol Therapeut"},{"key":"4652_CR14","doi-asserted-by":"crossref","first-page":"571085","DOI":"10.3389\/fimmu.2020.571085","volume":"11","author":"N Fine","year":"2020","unstructured":"Fine N, Tasevski N, McCulloch CA, Tenenbaum HC, Glogauer M. The neutrophil: constant defender and first responder. Front Immunol. 2020;11:571085.","journal-title":"Front Immunol"},{"key":"4652_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159\u201375.","journal-title":"Nat Rev Immunol"},{"key":"4652_CR16","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298.","journal-title":"Front Immunol"},{"key":"4652_CR17","doi-asserted-by":"crossref","first-page":"828354","DOI":"10.1155\/2013\/828354","volume":"2013","author":"A Schiopu","year":"2013","unstructured":"Schiopu A, Cotoi OS. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediat Inflamm. 2013;2013:828354.","journal-title":"Mediat Inflamm"},{"key":"4652_CR18","doi-asserted-by":"crossref","first-page":"105212","DOI":"10.1016\/j.phrs.2020.105212","volume":"161","author":"S Gopalkrishna","year":"2020","unstructured":"Gopalkrishna S, Ahmed AL, Andrew JM, Prabhakara RN. Emerging roles of neutrophil-borne S100A8\/A9 in cardiovascular inflammation. Pharmacol Res. 2020;161:105212.","journal-title":"Pharmacol Res"},{"key":"4652_CR19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/rccm.200810-1552OC","volume":"180","author":"MAD van Zoelen","year":"2009","unstructured":"van Zoelen MAD, Vogl T, Foell D, Veen SQV, van Till JWO, Florquin S, et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Respir Crit Care. 2009;180:1098\u2013106.","journal-title":"Am J Respir Crit Care"},{"key":"4652_CR20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ajem.2015.06.025","volume":"33","author":"S Gao","year":"2015","unstructured":"Gao S, Yang Y, Fu Y, Guo W, Liu G. Diagnostic and prognostic value of myeloid-related protein complex 8\/14 for sepsis. Am J Emerg Med. 2015;33:1278\u201382.","journal-title":"Am J Emerg Med"},{"key":"4652_CR21","first-page":"1","volume":"80","author":"A Larsson","year":"2019","unstructured":"Larsson A, Tyd\u00e9n J, Johansson J, Lipcsey M, Bergquist M, Kultima K, et al. Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scand J Clin Lab Investig. 2019;80:1\u20136.","journal-title":"Scand J Clin Lab Investig"},{"key":"4652_CR22","doi-asserted-by":"crossref","first-page":"15660","DOI":"10.1038\/s41598-019-52184-8","volume":"9","author":"C Dubois","year":"2019","unstructured":"Dubois C, Marc\u00e9 D, Faivre V, Lukaszewicz A-C, Junot C, Fenaille F, et al. High plasma level of S100A8\/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients. Sci Rep. 2019;9:15660.","journal-title":"Sci Rep"},{"key":"4652_CR23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/diagnostics10110990","volume":"10","author":"TH Wirtz","year":"2020","unstructured":"Wirtz TH, Buendgens L, Weiskirchen R, Loosen SH, Haehnsen N, Puengel T, et al. Association of serum calprotectin concentrations with mortality in critically ill and septic patients. Diagnostics. 2020;10:990.","journal-title":"Diagnostics"},{"key":"4652_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s44161-022-00108-7","volume":"1","author":"M Su","year":"2022","unstructured":"Su M, Chen C, Li S, Li M, Zeng Z, Zhang Y, et al. Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis. Nat Cardiovasc Res. 2022;1:732\u201347.","journal-title":"Nat Cardiovasc Res"},{"key":"4652_CR25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.diagmicrobio.2018.10.006","volume":"93","author":"E Bart\u00e1kov\u00e1","year":"2019","unstructured":"Bart\u00e1kov\u00e1 E, \u0160tefan M, Str\u00e1n\u00edkov\u00e1 A, Posp\u00ed\u0161ilov\u00e1 L, Arientov\u00e1 S, Beran O, et al. Calprotectin and calgranulin C serum levels in bacterial sepsis. Diagn Microbiol Infect Dis. 2019;93:219\u201326.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4652_CR26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MAD, et al. Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007;13:1042\u20139.","journal-title":"Nat Med"},{"key":"4652_CR27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"4652_CR28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13613-022-01030-8","volume":"12","author":"S Jansson","year":"2022","unstructured":"Jansson S, Blixt PJ, Didriksson H, Jonsson C, Andersson H, Hedstr\u00f6m C, et al. Incidence of acute myocardial injury and its association with left and right ventricular systolic dysfunction in critically ill COVID-19 patients. Ann Intensive Care. 2022;12:56.","journal-title":"Ann Intensive Care"},{"key":"4652_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"4652_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-020-06262-5","volume":"47","author":"F Sanfilippo","year":"2021","unstructured":"Sanfilippo F, Huang S, Herpain A, Balik M, Chew MS, Clau-Terr\u00e9 F, et al. The PRICES statement: an ESICM expert consensus on methodology for conducting and reporting critical care echocardiography research studies. Intensiv Care Med. 2021;47:1\u201313.","journal-title":"Intensiv Care Med"},{"key":"4652_CR31","doi-asserted-by":"crossref","first-page":"e0162971","DOI":"10.1371\/journal.pone.0162971","volume":"11","author":"S-M Kuo","year":"2016","unstructured":"Kuo S-M. Gender difference in bacteria endotoxin-induced inflammatory and anorexic responses. PLOS ONE. 2016;11:e0162971.","journal-title":"PLOS ONE"},{"key":"4652_CR32","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehz461","volume":"40","author":"G Marinkovi\u0107","year":"2019","unstructured":"Marinkovi\u0107 G, Larsen HG, Yndigegn T, Szabo IA, Mares RG, de Camp L, et al. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Eur Heart J. 2019;40:2713\u201323.","journal-title":"Eur Heart J"},{"key":"4652_CR33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1872-034X.2011.00852.x","volume":"41","author":"SD Wei","year":"2011","unstructured":"Wei SD, Li JZ, Liu ZJ, Chen Q, Chen Y, Chen M, et al. Dexamethasone attenuates lipopolysaccharide-induced liver injury by downregulating glucocorticoid-induced tumor necrosis factor receptor ligand in Kupffer cells. Hepatol Res. 2011;41:989\u201399.","journal-title":"Hepatol Res"},{"key":"4652_CR34","doi-asserted-by":"crossref","first-page":"H733","DOI":"10.1152\/ajpheart.00339.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Kassiri Z, Virag JAI, de Br\u00e1s LEC, Scherrer-Crosbie M. Guidelines for measuring cardiac physiology in mice. Am J Physiol Heart C. 2018;314:H733\u201352.","journal-title":"Am J Physiol Heart C"},{"key":"4652_CR35","doi-asserted-by":"crossref","first-page":"e13564","DOI":"10.1111\/acel.13564","volume":"21","author":"D Bou-Teen","year":"2022","unstructured":"Bou-Teen D, Fernandez-Sanz C, Miro-Casas E, Nichtova Z, Bonzon-Kulichenko E, Cas\u00f3s K, et al. Defective dimerization of FoF1-ATP synthase secondary to glycation favors mitochondrial energy deficiency in cardiomyocytes during aging. Aging Cell. 2022;21:e13564.","journal-title":"Aging Cell"},{"key":"4652_CR36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/cvr\/cvv279","volume":"109","author":"L Valls-Lacalle","year":"2016","unstructured":"Valls-Lacalle L, Barba I, Mir\u00f3-Casas E, Alburquerque-B\u00e9jar JJ, Ruiz-Meana M, Fuertes-Agudo M, et al. Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition. Cardiovasc Res. 2016;109:374\u201384.","journal-title":"Cardiovasc Res"},{"key":"4652_CR37","doi-asserted-by":"crossref","first-page":"ftw111","DOI":"10.1093\/femspd\/ftw111","volume":"74","author":"M Valeri","year":"2016","unstructured":"Valeri M, Raffatellu M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis. 2016;74:ftw111.","journal-title":"Pathog Dis."},{"key":"4652_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","volume":"33","author":"H Yoshida","year":"2015","unstructured":"Yoshida H, Hunter CA. The immunobiology of interleukin-27. Annu Rev Immunol. 2015;33:417\u201343.","journal-title":"Annu Rev Immunol"},{"key":"4652_CR39","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/MCB.23.7.2564-2576.2003","volume":"23","author":"JAR Hobbs","year":"2003","unstructured":"Hobbs JAR, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, et al. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol. 2003;23:2564\u201376.","journal-title":"Mol Cell Biol"},{"key":"4652_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jss.2016.01.019","volume":"202","author":"S Hofer","year":"2016","unstructured":"Hofer S, Uhle F, Fleming T, Hell C, Schmoch T, Bruckner T, et al. RAGE-mediated inflammation in patients with septic shock. J Surg Res. 2016;202:315\u201327.","journal-title":"J Surg Res"},{"key":"4652_CR41","doi-asserted-by":"crossref","first-page":"e003865","DOI":"10.1161\/CIRCIMAGING.115.003865","volume":"8","author":"V Palmieri","year":"2018","unstructured":"Palmieri V, Innocenti F, Guzzo A, Guerrini E, Vignaroli D, Pini R. Left ventricular systolic longitudinal function as predictor of outcome in patients with sepsis. Circ Cardiovasc Imaging. 2018;8:e003865.","journal-title":"Circ Cardiovasc Imaging"},{"key":"4652_CR42","doi-asserted-by":"crossref","unstructured":"Sreejit G, Nooti SK, Jaggers RM, Athmanathan B, Park KH, Al-Sharea A, et al. Retention of the NLRP3 inflammasome-primed neutrophils in the bone marrow is essential for myocardial infarction-induced granulopoiesis. Circulation. 2021.","DOI":"10.1161\/CIRCULATIONAHA.121.056019"},{"key":"4652_CR43","doi-asserted-by":"crossref","first-page":"e72138","DOI":"10.1371\/journal.pone.0072138","volume":"8","author":"J-C Simard","year":"2013","unstructured":"Simard J-C, Cesaro A, Chapeton-Montes J, Tardif M, Antoine F, Girard D, et al. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-\u03baB1. PLOS ONE. 2013;8:e72138.","journal-title":"PLOS ONE"},{"key":"4652_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2567.2012.03619.x","volume":"137","author":"M Riva","year":"2012","unstructured":"Riva M, K\u00e4llberg E, Bj\u00f6rk P, Hancz D, Vogl T, Roth J, et al. Induction of nuclear factor-\u03baB responses by the S100A9 protein is toll-like receptor-4-dependent. Immunology. 2012;137:172\u201382.","journal-title":"Immunology"},{"key":"4652_CR45","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar1939","volume":"8","author":"K Sunahori","year":"2006","unstructured":"Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, et al. The S100A8\/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther. 2006;8:R69.","journal-title":"Arthritis Res Ther"},{"key":"4652_CR46","doi-asserted-by":"crossref","first-page":"113405","DOI":"10.1016\/j.yexcr.2022.113405","volume":"421","author":"F Du","year":"2022","unstructured":"Du F, Ding Z, R\u00f6nnow C-F, Rahman M, Schiopu A, Thorlacius H. S100A9 induces reactive oxygen species-dependent formation of neutrophil extracellular traps in abdominal sepsis. Exp Cell Res. 2022;421:113405.","journal-title":"Exp Cell Res."},{"key":"4652_CR47","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.3390\/ijms222312923","volume":"22","author":"Z Ding","year":"2021","unstructured":"Ding Z, Du F, Averitt VRG, Jakobsson G, R\u00f6nnow C-F, Rahman M, et al. Targeting S100A9 reduces neutrophil recruitment, inflammation and lung damage in abdominal sepsis. Int J Mol Sci. 2021;22:12923.","journal-title":"Int J Mol Sci"},{"key":"4652_CR48","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCRESAHA.107.167544","volume":"102","author":"JH Boyd","year":"2008","unstructured":"Boyd JH, Kan B, Roberts H, Wang Y, Walley KR. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res. 2008;102:1239\u201346.","journal-title":"Circ Res"},{"key":"4652_CR49","doi-asserted-by":"crossref","first-page":"H2316","DOI":"10.1152\/ajpheart.00763.2001","volume":"282","author":"S Nemoto","year":"2002","unstructured":"Nemoto S, Vallejo JG, Knuefermann P, Misra A, Defreitas G, Carabello BA, et al. Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am J Physiol Heart C. 2002;282:H2316\u201323.","journal-title":"Am J Physiol Heart C"},{"key":"4652_CR50","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1089\/ars.2010.3728","volume":"15","author":"O Avlas","year":"2011","unstructured":"Avlas O, Fallach R, Shainberg A, Porat E, Hochhauser E. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility. Antioxid Redox Sign. 2011;15:1895\u2013909.","journal-title":"Antioxid Redox Sign"},{"key":"4652_CR51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li Y, Chen B, Yang X, Zhang C, Jiao Y, Li P, et al. S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury. Circulation. 2019;140:751\u201364.","journal-title":"Circulation"},{"key":"4652_CR52","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"4652_CR53","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCRESAHA.120.315865","volume":"127","author":"G Marinkovi\u0107","year":"2020","unstructured":"Marinkovi\u0107 G, Koenis DS, de Camp L, Jablonowski R, Graber N, de Waard V, et al. S100A9 links inflammation and repair in myocardial infarction. Circ Res. 2020;127:664\u201376.","journal-title":"Circ Res"},{"key":"4652_CR54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00134-017-4698-z","volume":"43","author":"F Boissier","year":"2017","unstructured":"Boissier F, Razazi K, Seemann A, Bedet A, Thille AW, de Prost N, et al. Left ventricular systolic dysfunction during septic shock: the role of loading conditions. Intensive Care Med. 2017;43:633\u201342.","journal-title":"Intensive Care Med"},{"key":"4652_CR55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-100-4-483","volume":"100","author":"MM Parker","year":"1984","unstructured":"Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100:483.","journal-title":"Ann Intern Med"},{"key":"4652_CR56","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc12741","volume":"17","author":"SJ Huang","year":"2013","unstructured":"Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care. 2013;17:R96.","journal-title":"Crit Care"},{"key":"4652_CR57","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pbio.1000097","volume":"7","author":"P Bj\u00f6rk","year":"2009","unstructured":"Bj\u00f6rk P, Bj\u00f6rk A, Vogl T, Stenstr\u00f6m M, Liberg D, Olsson A, et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. Plos Biol. 2009;7:e1000097.","journal-title":"Plos Biol"},{"key":"4652_CR58","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/gutjnl-2014-307118","volume":"64","author":"G D\u2019Haens","year":"2015","unstructured":"D\u2019Haens G, Sandborn WJ, Colombel JF, Rutgeerts P, Brown K, Barkay H, et al. A phase II study of laquinimod in Crohn\u2019s disease. Gut. 2015;64:1227.","journal-title":"Gut"},{"key":"4652_CR59","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","volume":"366","author":"G Comi","year":"2012","unstructured":"Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, et al. Placebo-controlled trial of oral laquinimod for multiple sclerosis. New Engl J Med. 2012;366:1000\u20139.","journal-title":"New Engl J Med"},{"key":"4652_CR60","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-021-02573-0","volume":"23","author":"R Hesselstrand","year":"2021","unstructured":"Hesselstrand R, Distler JHW, Riemekasten G, Wuttge DM, T\u00f6rngren M, Nyhl\u00e9n HC, et al. An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod. Arthritis Res Ther. 2021;23:204.","journal-title":"Arthritis Res Ther"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04652-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T08:14:28Z","timestamp":1704183268000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04652-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4652"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04652-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies were approved by the regional ethics committees in Lund or Link\u00f6ping, and were performed in compliance with EU guidelines and with the declaration of Helsinki. The SICU-2 study has been approved by the Swedish ethical review authority. All patients included in the study provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Michelle Chew is a member of the editorial board of Critical Care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}